Ipamorelin
Overview
Research-use selective growth hormone secretagogue supplied for studies of ghrelin receptor signaling and endocrine pathway models.
- Concentration
- 10 mg
- Stock
- In stock
Product details
Ipamorelin is a synthetic pentapeptide secretagogue used in research models of ghrelin receptor signaling and endocrine pathway biology. Pattern lists this material for controlled laboratory research.
Research Targets: Ghrelin receptor/GHS-R1a signaling, pituitary somatotroph pathways, calcium signaling models.
Key Feature: Selective pentapeptide secretagogue format for endocrine signaling studies.
Research Focus Areas: Growth hormone release profiles, pituitary signaling, bone and metabolic pathway models, receptor specificity studies.
Common Models: In vitro pituitary assays, rodent endocrine profiling, bone-regeneration pathway studies.
Mechanistic Interests: GHS-R1a activation, calcium mobilization, GH-axis signaling, off-target hormone marker comparisons.
Use Boundary: Research use only; not for human or veterinary use; no diagnostic, therapeutic, or consumption use is implied.
Research context
Peptide guide
Open full guide- Guide profile
- Growth Hormone-Releasing Peptide (GHRP)
- Composition
- Synthetic pentapeptide growth hormone secretagogue (GHS) that selectively binds to ghrelin/growth hormone secretagogue receptor (GHS-R1a)
- Discovery
- Developed in the late 1990s as part of research to create highly selective GH secretagogues with improved safety profiles compared to earlier GHRPs
- Research scope
- Preclinical and clinical studies demonstrate ipamorelin's selective GH-releasing effects with minimal impact on other hormones
- Regulatory status
- No FDA approval; lacks large-scale human RCTs for therapeutic claims. Used extensively in research, wellness, and compounded applications
Safety context
- Active cancer or tumor history (GH can promote cell proliferation)
- Diabetic retinopathy or proliferative conditions
- Hypersensitivity to ipamorelin or components
Research-use notice: Ipamorelin is a selective growth hormone secretagogue, but it is not FDA-approved for therapeutic use and remains investigational. Evidence for body composition, recovery, sleep, and aging-related claims is primarily mechanistic, animal-based, small-study, or uncontrolled. Long-term human safety data are limited, compounded quality varies, and clinical decisions require qualified medical oversight.
Full guide includes 10 reference entries.
One kit adds 10 vials to WooCommerce checkout.